PATENT CLAIM ANALYSIS

Application Number: 16127806
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-11
Patent Classification: ["514", "185000"]

Abstract:
A cancer treatment method using a Ni-SOD mimic compound is provided, which includes administrating the Ni-SOD compound to a cancer cell of a cancer. The structure of the Ni-SOD mimic compound is represented as follows: wherein R 1  represents H or A-R′; A represents a bond, O or N; L represents acetonitrile, water, or t-butyl isocyanate; R′ represents H, unsubstituted or substituted alkyl, polyalkoxy, polydimethylsiloxane, polyurethane or other polymer materials or amino acid groups; R 2  represents unsubstituted or substituted alkyl, alkoxy, siloxy, amino, alkylamine or hydrocarbyl groups; R 3  represents unsubstituted or substituted amino, alkylamine, oxyalkylamine groups or magnetic nanoparticles attached oxyalkylamine. Ni is bivalent or trivalent.

Claim (Index 2):
The cancer treatment method according to  claim 1 , wherein the Ni-SOD mimic compound has a structure represented by Formula (II) or (III) as follows:

Metadata:
- Claim Count in Document: 17.0
- Percentile: 97.0
- Lexical Diversity: 1.92647
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15445588', '14922555', '14369153', '12865668', '12954038']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7477847232742326
- 35 USC 102 Novelty (BERT): 0.5115530418283389
- Combined Prediction Score: 0.7241615551296432
- Mean Citation Score: 207.52592
- Max Citation Score: 210.18033
- Similarity Product: 118.3911751943958

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test